Granitryl 3mg 3 ml

Granitryl 3mg 3 ml

Description:

Granitryl 3mg 3 ml is a prescription antiemetic injection containing granisetron, a selective 5ht3 receptor antagonist. It is used in hospitals and oncology settings to prevent and treat nausea and vomiting associated with cytotoxic chemotherapy and radiotherapy. This sterile intravenous solution is designed for short-term use under direct medical supervision to control acute and delayed chemotherapy-induced nausea and vomiting, improving patient comfort and treatment tolerance.

Indications:

• Prevention of nausea and vomiting associated with cytotoxic chemotherapy.
• Treatment of established nausea and vomiting induced by chemotherapy.
• Prevention of nausea and vomiting associated with radiotherapy.
• May be used as part of an antiemetic regimen in oncology patients as directed by a specialist physician.

Active Ingredients / Key Components:

• Granisetron hydrochloride – 3 mg per 3 ml ampoule (equivalent to 1 mg granisetron per 1 ml). Exact salt form and excipient concentrations beyond this , please check the product leaflet or the manufacturer’s official website.
• Excipients: sterile solution for intravenous use (full excipient list and concentrations , please check the product leaflet or the manufacturer’s official website).

Dosage & Administration / How to Use:

• Granitryl 3mg 3 ml is for intravenous use only and must be administered by healthcare professionals.
• Adults (chemotherapy-induced nausea and vomiting): typical dosing regimens may include a single iv dose given shortly before chemotherapy, or divided doses as per protocol. The exact dose, infusion rate, and timing must follow the prescribing information and the treating oncologist’s instructions. Specific standard dose schedules are not provided in the available data and must be taken from the official product leaflet.
• Radiotherapy-induced nausea and vomiting: dose and timing are determined by the physician according to the radiotherapy protocol and patient condition.
• Administration: usually given as a slow iv injection or short infusion, often diluted in a compatible infusion fluid as recommended in the official prescribing information.
• Use in children, elderly patients, or those with hepatic or renal impairment requires dose adjustment and careful monitoring by a physician.
• Do not self-administer. Use only in a clinical setting where resuscitation equipment and medical supervision are available.

Clinical Benefits:

• Effectively prevents and controls chemotherapy-induced nausea and vomiting, improving patient comfort during cancer treatment.
• Helps reduce the risk of dehydration, electrolyte imbalance, and nutritional compromise due to persistent vomiting.
• Supports better adherence to chemotherapy and radiotherapy schedules by minimizing treatment-related nausea and vomiting.
• Selective 5ht3 receptor antagonism provides targeted antiemetic action with a favorable efficacy profile in oncology practice.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to granisetron or any component of the formulation.
• Use with caution in patients with a history of cardiac arrhythmias, prolonged qt interval, or those receiving other medicines that may prolong the qt interval (such as certain antiarrhythmics, antipsychotics, or antibiotics).
• Caution in patients with severe hepatic impairment, as dosage adjustment and close monitoring may be required.
• May mask progressive ileus or gastric distension; use carefully in patients with recent abdominal surgery or suspected bowel obstruction.
• Consult your doctor before use if pregnant or nursing; use only if the potential benefit justifies the potential risk to the fetus or infant.
• Inform your doctor about all medications you are taking, including other antiemetics, antidepressants, antiarrhythmics, and any qt-prolonging drugs.
• Not intended for self-medication or over-the-counter use; this is a prescription-only medicine.
• Keep out of reach of children.

Side Effects:

• Common side effects may include headache, constipation, diarrhea, dizziness, or fatigue.
• Less common side effects can include changes in liver function tests, abdominal pain, or transient blood pressure changes.
• Serious but rare side effects may include hypersensitivity reactions (rash, pruritus, urticaria, bronchospasm, anaphylaxis), serotonin syndrome (especially when combined with other serotonergic drugs), or cardiac rhythm disturbances including qt prolongation.
• Seek immediate medical attention if you experience chest pain, severe dizziness, fainting, palpitations, difficulty breathing, swelling of the face or throat, or severe skin reactions.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not freeze. Do not use after the expiry date printed on the pack. Use only clear, particle-free solution; discard if the solution appears discolored or contains particles.

Specifications:

• Product type: Prescription antiemetic medicine for intravenous use.
• Active ingredient: granisetron 3 mg per 3 ml ampoule.
• Form: sterile solution for injection (iv ampoule).
• Pack size: typically supplied as multiple iv ampoules per box (exact count not specified in the provided information).

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.